ALXO
Alx Oncology Holdings Inc

1,242
Loading...
Loading...
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
80

Frequently Asked Questions

What is Market Cap of Alx Oncology Holdings Inc?
What is the 52-week high for Alx Oncology Holdings Inc?
What is the 52-week low for Alx Oncology Holdings Inc?
What is Alx Oncology Holdings Inc stock price today?
What was Alx Oncology Holdings Inc stock price yesterday?
What is the PE ratio of Alx Oncology Holdings Inc?
What is the Price-to-Book ratio of Alx Oncology Holdings Inc?
What is the 50-day moving average of Alx Oncology Holdings Inc?
How many employess does Alx Oncology Holdings Inc has?

Latest ALXO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.